250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical VC (Venture Capital) Funds in Denmark in September 2025

A list of 50 VC (Venture Capital) funds that invest in Medical startups based in Denmark. We rank investors based on the number of investments they made in Medical companies from Denmark. We update this investor list every month.

Top 50 Medical VC (Venture Capital) Funds in Denmark in September 2025

Investor Medical Denmark investments
BioInnovation Institute 12
Novo Holdings 9
Vaekstfonden 6
Export and Investment Fund 4
Vaekstfonden 4
Seed Capital 3
Sunstone Life Science Ventures 3
CAPNOVA 2
People Ventures 2
VentureFriends 2
Forbion Capital Partners 2
Wellcome Trust 2
Innovation Fund Denmark 2
PSV 2
Crowberry Capital 2
Cormorant Asset Management 1
Sagitta Ventures 1
SOSV 1
LSP BioVentures 1
SLS Venture 1
Danske Bank 1
AdBio partners 1
Roche Venture Fund 1
Nucleus Capital 1
Sanofi Ventures 1
Eli Lilly 1
North Ventures 1
Nucleus Capital 1
LF Investment 1
Polaris Partners 1
Seventure Partners 1
Bioqube Ventures 1
New Enterprise Associates 1
Sound Bioventures 1
CBC Investment Group 1
M Ventures 1
BlueYard Capital 1
Amino Collective 1
Inovo.vc 1
Den Midtjyske Inværksätterfond 1
Bossanova Investimentos 1
SEB Venture Capital 1
BankInvest Biomedical Venture 1
Dansk Erhvervsinvestering 1
VIB 1
LS Polaris Innovation Fund 1
Novo Ventures 1
Droia Ventures 1
DigitalDx Ventures 1
V-Bio Ventures 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
BioInnovation Institute VC Fund · Copenhagen, Hovedstaden, Denmark
BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Convertible Note, Pre-Seed, Debt Financing
  • Denmark, Germany, Switzerland
Portfolio highlights
  • NorFalk — Explore NorFalk and its new generation surfactants. Discover our specializations and subscribe to our newsletter today.
  • ArcanaBio — ArcanaBio is developing realtime biosurveillance solutions that minimize workplace disruptions and support health & wellness
  • Fuse Vectors — Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy.
Novo Holdings VC Fund · Hellerup, Hovedstaden, Denmark · 22 investments in the past 12 months
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, Denmark, United Kingdom
Portfolio highlights
  • Mission Bio — We offer the only multi-omics single-cell technology solution that simultaneously detects SNV, CNV, and protein data from the same cell. Find out more.
  • Sparrow Quantum — Sparrow Quantum, a global leader in quantum photonic chip technology. Explore innovative solutions driving advancements in quantum computing, communication, and beyond. Stay ahead with cutting-edge technologies shaping the future.
  • Reunion Neuroscience — Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions. The Company’s lead asset, RE104, is a proprietary, novel serotonergic psychedelic compound being developed as a potential fast-acting and durable antidepressant for patients suffering from postpartum depressionand other mental health conditions. Reunion is also developing the RE200 series, which includes compounds with the potential for more selective serotonin receptor activity and reduced psychoactivity for application in more chronic treatment paradigms and indications.
Vaekstfonden VC Fund · Hellerup, Hovedstaden, Denmark
Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Seed, Funding Round, Pre-Seed
  • Denmark, United States, United Kingdom
Portfolio highlights
  • Wedio — Buy & Rent professional film equipment from trusted creators near you. Buy & rent cameras, lenses, drones with Global Coverage. Explore
  • Keepit — The Keepit Cloud is the most cost-effective solution on the market with 20+ years of experience. Learn more about our next-level data protection services
  • kleen hub — Kleen hub is Denmark's first digital return system for reusable coffee cups and food packaging.
Export and Investment Fund VC Fund · Hellerup, Hovedstaden, Denmark · 26 investments in the past 12 months
Denmark's Export and Investment Fund (EIFO) serves as a single point of contact for Danish firms seeking risk-tolerant government finance. We aspire to help successful enterprises that can expand the Danish economy and green the world on a daily basis, guided by professionalism and an international perspective.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • Denmark, United States, United Kingdom
Portfolio highlights
  • Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
  • Propane — Propane is an AI-powered operating system for customer intelligence, built for modern product and GTM teams. It automates continuous customer and user research through embedded AI agents, integrated workflows, and real-time analysis—turning feedback into a scalable system, not a one-off task.
  • Interhuman — Interhuman is an artificial intelligence company that develops social-aware AI for real-time communication purposes.
Vaekstfonden VC Fund · Hellerup, Hovedstaden, Denmark
Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Seed, Funding Round, Pre-Seed
  • Denmark, United States, Norway
Portfolio highlights
  • Wedio — Buy & Rent professional film equipment from trusted creators near you. Buy & rent cameras, lenses, drones with Global Coverage. Explore
  • Keepit — The Keepit Cloud is the most cost-effective solution on the market with 20+ years of experience. Learn more about our next-level data protection services
  • kleen hub — Kleen hub is Denmark's first digital return system for reusable coffee cups and food packaging.
Seed Capital VC Fund · Copenhagen, Hovedstaden, Denmark · 3 investments in the past 12 months
Seed Capital invests in Danish tech businesses with global ambitions. We are focused on "late seed"-stage companies, typically investing 1-3 MEUR in rounds of 1-6 MEUR. Proud backers of Trustpilot, Vivino, Lunar, Templafy, Dixa, Forecast, and many other great companies.
Show more
Investment focus
  • Software, Health Care, SaaS
  • Seed, Funding Round, Series A
  • Denmark, United States, United Kingdom
Portfolio highlights
  • Tembi — Market Intelligence platform with deep market data, insights and predictions for B2B companies that look for a competitive edge.
  • Fortiv — We help enterprise Resilience teams implement a Business Continuity Management System
  • Embankment Group — Specializing in environmental recruitment, we connect top talent with exciting projects. Contact us to find your ideal candidate today!
Sunstone Life Science Ventures VC Fund · Copenhagen, Hovedstaden, Denmark
Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Funding Round, Series B, Series A
  • Denmark, Sweden, Switzerland
Portfolio highlights
  • Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
  • Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
  • Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
CAPNOVA VC Fund · Aarhus, Midtjylland, Denmark
They are an investment and development company providing capital, solid business experience and a strong network in order to turn innovative ideas into successful businesses. They cover all of Denmark from their offices in Aarhus, Roskilde, Copenhagen, Viborg and Kalundborg.
Show more
Investment focus
  • Software, Information Technology, Internet
  • Funding Round, Seed, Pre-Seed
  • Denmark, United States, India
Portfolio highlights
  • Ulobby — Ulobby is an automated tool for stakeholder management and political monitoring
  • Mechanic Miner — Mechanic Miner is a 2D construction/survival game with mechanical steam-powered machines. You are stranded on a strange and forbidding planet, where survival is made difficult by hostile animals and plant life. From your home world you did bring a multitool, which is able to craft any kind of machine part - provided the requisite rawmaterials can be found. Relying solely on the technology you brought, you set out to explore a whole world. You can progress through the game by acquiring new types of steam-powered technology elements, that are necessary to delve deeper into the diverse biomes of the planet, and perhaps, ultimately, discover the means to escape. You can construct any kind of machine of your own design - and any kind of machine can be simulated by the game's physics engine - and of course, designs can be shared with your friends.
  • ResoTher Pharma — ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on developing peptide-based drugs derived from the endogenous immunomodulator Annexin 1A as resolution therapy for diseases where neutrophil-driven inflammation plays a key pathological role.
People Ventures VC Fund · Taastrup, Hovedstaden, Denmark
People Ventures are your dreamcast team of co-founders, investors, executives, engineers, academics and industry experts. Together with talented entrepreneurs — We shape fantastic businesses through operational and commercial execution.
Show more
Investment focus
  • Health Care, Internet of Things, Software
  • Seed, Pre-Seed, Series A
  • Denmark, Sweden, United States
Portfolio highlights
  • Tiimo — Tiimo helps you manage your daily life and improve your wellbeing. Visualize your day. Improve your routines. Stress less.
  • proemial — Proem is open sourcing all our AI tools for science. After serving 100k+ users, we're making our research-grounded AI tools available to the community.
  • Version Lens — Meet your new Product Management Co-Pilot. Reduce overhead for your product team so you can focus on what truly matters, building outstanding products.
VentureFriends VC Fund · Athens, Attiki, Greece · 7 investments in the past 12 months
Backing ambitious early-stage founders across Europe and MENA
Show more
Investment focus
  • FinTech, E-Commerce, Software
  • Seed, Series A, Pre-Seed
  • Greece, United Kingdom, United States
Portfolio highlights
  • Retab — Cube AI boosts back-office logistics efficiency, allowing teams to handle more loads and focus on human relationships.
  • Unosecur — Unosecur is a cloud security platform that helps organizations detect, quantify, remediate and centrally manage identity and access risks across multi-clouds at all times.
  • Capalo AI — We maximize the value of your energy storage systems. Now and in the future.
Forbion Capital Partners VC Fund · Naarden, Noord-Holland, The Netherlands · 13 investments in the past 12 months
Impacting the future of medicine.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, United Kingdom, The Netherlands
Portfolio highlights
  • Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
  • Eeden — Eeden engages in the manufacture and supply of textiles.
  • Granite Bio — Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting pathogenic cells with the potential to transform inflammatory and fibrotic diseases.
Wellcome Trust VC Fund · London, England, United Kingdom
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Grant, Series C, Funding Round
  • United States, United Kingdom, Germany
Portfolio highlights
  • RenBio — RenBio develops antibody-based therapeutic solutions for the treatment of cancer and inflammatory diseases. RenBio's proprietary MYO technology involves in the development of antibody therapeutic that helps in treating rare diseases, viral infections, autoimmune diseases, and more by using DNA blueprint and antibody factory.
  • Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
  • Cultivarium — We develop molecular, hardware and software tools to accelerate the adoption of microbes for beneficial biotechnologies.
Innovation Fund Denmark VC Fund · Copenhagen, Hovedstaden, Denmark
Innovation Fund Denmark invests in the development of new knowledge and technology creating growth and employment in Denmark. The Fund focuses on societal challenges, strengthens research, and increases innovation commitment within private companies.The Fund provides risk capital that enables cutting-edge initiatives to achieve resultssubstantially impacting the Danish society. Innovation Fund Denmark is also responsible for the future societal partnerships, where companies, universities, and public authorities will work together on challenges facing the society today.
Show more
Investment focus
  • Software, Biotechnology, SaaS
  • Grant, Pre-Seed, Seed
  • Denmark, United States
Portfolio highlights
  • SureShot — SureShot empowers you and your audience to become video co-creators. With our cutting-edge AI, capture, edit, and share electrifying videos that amplify the essence of every event.
  • FEESH — FEESH is a groundbreaking biotech company developing sustainable protein alternatives targeted at the aquaculture industry.
  • Tailwind Biotech — AI-powered synthetic DNA design services for improved strain development. We use Artificial Intelligence to help biotech companies achieve more effective and more efficient bioproduction processes. Our technology designs best-in-class synthetic DNA Promoters and Terminators, and performs gene codon optimizations that help to maximise biomanufacturing yields while reducing development costs.
PSV VC Fund · Lyngby, Hovedstaden, Denmark
PreSeed Ventures are the preferred travel companion for trailblazing founders when they set out on the journey of transforming startup dreams to successful businesses. Founded in 2000 they have an exceptional track record of spotting, fostering and financing tomorrow’s winners in syndication with top-tier investors locally and globally. As the namesuggests, PreSeed Ventures operates at the earliest stages, where founders need the professional, operational & systematic support of a VC, but the risks are still too high for most VCs in seed stages. Yet to the powerhouse of experts behind PreSeed Ventures, who have experience from hundreds of startup journey in the pre-seed stage, it is an opportunity to support and nurture the growth of promising startups on the rise, minimizing the time and risk to the next investment round.PreSeed Ventures has grown out of the technological research environment at Denmark’s Technical University, DTU. In 2020 they launch their first full blown commercial venture fund, yet continuing to be a subsidiary company to the university.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Seed, Pre-Seed, Funding Round
  • Denmark, United States, United Kingdom
Portfolio highlights
  • ZTLment — We empower online platforms and marketplaces to seamlessly hold, manage, and distribute funds in real-time, with full automation and compliance.
  • Dynelectro — Dynelectro is a Danish solid oxide electrolyser equipment manufacturer with proprietary innovation to lower the total cost of hydrogen. Dynamic operation enables load-follow of fluctuating renewable energy, delivering over 85% electrical efficiency prior to integrating with industrial heat sources. With fully reversable operation, electricity generation adds substantial value and flexibility with grid ancillary services. Small-scale units begin at 40 kW with 12-month lead time. Large-scale systems start at 1 MW with project-based lead time.
  • Interhuman — Interhuman is an artificial intelligence company that develops social-aware AI for real-time communication purposes.
Crowberry Capital VC Fund · Reykjavík, Gullbringusysla, Iceland · 2 investments in the past 12 months
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more
Investment focus
  • Software, Gaming, Health Care
  • Seed, Series A, Pre-Seed
  • Iceland, Denmark, Finland
Portfolio highlights
  • Tiimo — Tiimo helps you manage your daily life and improve your wellbeing. Visualize your day. Improve your routines. Stress less.
  • Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
  • Porcelain Fortress — Porcelain Fortress was founded by a small band of romantics in the summer of 2016 in Reykjavik, Iceland.
Cormorant Asset Management VC Fund · Boston, Massachusetts, United States · 11 investments in the past 12 months
Cormorant Asset Management is an employee-owned hedge fund sponsor that provides its services to pooled investment vehicles. The firm also focuses on both public and private market innovative companies in the biotechnology and life sciences marketplace.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, China, Switzerland
Portfolio highlights
  • Numab — Numab Therapeutics AG
  • Neurona Therapeutics — Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeuticcompositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.
  • Edgewise Therapeutics — See how we bring our unique expertise and singular focus on muscle science to develop novel therapeutics for serious skeletal and cardiac muscle diseases.
Sagitta Ventures VC Fund · Copenhagen, Hovedstaden, Denmark
Sagitta Ventures invests in early-stage companies in the Nordics and provides long-term capital backing for well-managed businesses that are seeking minority investors without a defined exit horizon.
Show more
Investment focus
  • Aerospace
  • Series B
  • Sweden
Portfolio highlights
  • Cerebriu — Cerebriu is a health tech company developing machine learning in medical imaging that improves workflow efficiency and quality in radiology.Its software solution Cerebriu Apollo achieves the company's aim by automating image acquisition protocols and triage during MRI brain acquisition providing decision support at key stages of thediagnostic process. The company covers findings of the brain, starting with brain MRI, including stroke, bleeds, and tumors, following MS, dementia, and TBI in brain CT.
  • Ward 24/7 — Ward 24/7 develops a wireless assessment of respiratory and circulatory distress to monitor and observe high-risk patients. Its intelligent clinical support system monitors oxygen saturation, respiratory rate, cardiac function, and other parameters for patients suspected of circulatory and respiratory distress. With a series of wirelesssensors that transmit data to a server and artificial intelligence that monitors the incoming data and alerts staff to potentially critical situations, it helps healthcare providers to have the proper equipment for diagnosis.The company was founded in 2016 and is headquartered in Copenhagen, Denmark.
  • Heart Aerospace — Heart’s mission is to create the fastest, most affordable and sustainable transportation for regional travel to every corner of the world. Their first aircraft is the ES-19, a nineteen-passenger airliner with an operating range of 400 km. Heart's goal is to have the aircraft certified for commercial operation by 2026.
SOSV VC Fund · Princeton, New Jersey, United States · 75 investments in the past 12 months
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Convertible Note, Pre-Seed
  • United States, India, United Kingdom
Portfolio highlights
  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
LSP BioVentures VC Fund · Cambridge, Massachusetts, United States
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, Germany, United Kingdom
Portfolio highlights
  • Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
  • Muna Therapeutics — Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
  • HotSpot Therapeutics — HotSpot Therapeutics is a biotech startup that focuses on the development of allosteric therapies targeting regulatory sites on proteins. It develops a therapy platform to discover medicines and provide proper treatment to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspotstructures, harnessing the power of data science in its multidisciplinary approach to drug discovery, and helps patients to get treatment against several diseases.HotSpot Therapeutics was founded in 2017 and is headquartered in Boston, Massachusetts.
SLS Venture VC Fund · Stockholm, Stockholms Lan, Sweden
Get full access to this domain. Easy, seamless transactions. Zero percent financing available.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series C, Funding Round, Series A
  • Denmark, United States, Sweden
Portfolio highlights
  • AdvanDx — I found a great domain name for sale on Dan.com. Check it out!
  • OxThera — OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria. OxThera’s intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria, and enzymes. Oxabact® holds Orphan Drug designations in Europe and in the US for thetreatment of primary hyperoxaluria.
  • Action Pharma — Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modifiedÐMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.
Danske Bank VC Fund · Copenhagen, Hovedstaden, Denmark · 4 investments in the past 12 months
Danske Bank is a Nordic universal bank offering a full range of banking services. It was founded 5 October 1871 as Den Danske Landmandsbank, Hypothek- og Vexelbank i Kjøbenhavn (The Danish Farmers' Bank, Mortgage and Exchange Bank of Copenhagen). It is headquartered in Copenhagen, Denmark and is one of the major retail banks in the northernEuropean region with over 5 million retail customers.Danske Bank was number 454 on the Fortune Global 500 list for 2011.
Show more
Investment focus
  • Biotechnology, Apps, Payments
  • Funding Round, Post-IPO Debt, Debt Financing
  • Denmark, Sweden, United States
Portfolio highlights
  • Mowi — Home - Mowi Company Website
  • Helen — Helen sell electricity to about 450,000 customers and heat more than 90 percent of Helsinki's properties with district heating.
  • Polypeptide Group — The PolyPeptide Group is a contract manufacturing organization for peptides and peptide related molecules. A global presence throughout the world assures our clients a reliable supply with the necessary capacity for an uninterrupted service.The Group is one of the world’s largest independent contract manufacturers of therapeutic peptides forthe cosmetic, pharmaceutical and veterinary markets employing more than 450 people in six manufacturing sites located in France, India, Scandinavia and the USA.PolyPeptide Group is privately-held organization that manufactures over one third of all approved peptide drug substances (22 of 62 approved products worldwide) accounting for over 25% of the sales of outsourced peptide therapeutics worldwide.
AdBio partners VC Fund · Paris, Ile-de-France, France · 2 investments in the past 12 months
AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Seed, Series A, Funding Round
  • France, Spain, Belgium
Portfolio highlights
  • Cephagenix — Cephagenix focuses on identifying and developing new, effective migraine therapies.
  • Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
  • Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
Roche Venture Fund VC Fund · Basel, Basel-Stadt, Switzerland
We are the corporate venture fund of Roche, a global leader in bringing medicines and in vitro diagnostics to the benefit of patients.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, United Kingdom, Spain
Portfolio highlights
  • DiogenX — Welcome to DiogenX. Explore our pioneering research and innovative therapies aimed at transforming diabetes treatment
  • Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
  • MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Nucleus Capital VC Fund · Berlin, Berlin, Germany · 6 investments in the past 12 months
Supporting purpose-driven founders solving systemic challenges to planetary health.
Show more
Investment focus
  • Biotechnology, Food and Beverage, Manufacturing
  • Pre-Seed, Seed, Series A
  • Germany, United States, United Kingdom
Portfolio highlights
  • Koppie — Saving your daily (coffee) ritual, with local, sustainable solutions.
  • ScienceMachine — Revolutionize your scientific research with AI-powered data analysis. ScienceMachine makes your work 100 times faster and more efficient | Science Machine Inc.
  • Izote Biosciences — Biomanufacturing Scale-Up Solution
Sanofi Ventures VC Fund · Cambridge, Massachusetts, United States · 13 investments in the past 12 months
Sanofi Ventures invests in top tier biotherapeutic and digital health entrepreneurs who focus on helping patients and transforming the healthcare system.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, United Kingdom, France
Portfolio highlights
  • Therini Bio — Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
  • Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
  • Draig Therapeutics — Draig Therapeutics is a clinical-stage biopharmaceutical startup dedicated to creating next-generation treatments for serious neuropsychiatric illnesses.
Eli Lilly VC Fund · Indianapolis, Indiana, United States · 17 investments in the past 12 months
Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conductsresearch to find products to treat diseases in animals and to increase the efficiency of animal food production.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Funding Round
  • United States, United Kingdom, Canada
Portfolio highlights
  • Therini Bio — Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
  • Signify Bio — Signify Bio combines the promise of signal peptide engineered control with the speed and power of mRNA encoded design.
  • Stylus Medicine — Stylus Medicine, Inc. is a biotechnology company dedicated to developing transformative in vivo genetic medicines.
North Ventures VC Fund · Copenhagen, Hovedstaden, Denmark
North Ventures is a venture capital firm investing in technology-driven companies from Seed to Series A in Denmark and across the Nordics.
Show more
Investment focus
  • Financial Services
  • Series A
  • Denmark
Portfolio highlights
  • Monthio — Embrace the future of lending with Open Banking for credit decisioning. Streamline loan applications, increase accessibility, and deliver exceptional customer service.
  • Cerebriu — Cerebriu is a health tech company developing machine learning in medical imaging that improves workflow efficiency and quality in radiology.Its software solution Cerebriu Apollo achieves the company's aim by automating image acquisition protocols and triage during MRI brain acquisition providing decision support at key stages of thediagnostic process. The company covers findings of the brain, starting with brain MRI, including stroke, bleeds, and tumors, following MS, dementia, and TBI in brain CT.
Nucleus Capital VC Fund · Berlin, Berlin, Germany
Supporting purpose-driven founders solving systemic challenges to planetary health.
Show more
Investment focus
  • Biotechnology, Information Technology, Food and Beverage
  • Pre-Seed, Seed, Series A
  • Germany, United Kingdom, United States
Portfolio highlights
  • Planet A Foods — The chocolate revolution is here. 100% cocoa-free and unbelievably delicious. We call it QOA. You need to try it!
  • Ucaneo — We Leveraging the magic of the human body to remove CO2 from the air.
  • Izote Biosciences — Biomanufacturing Scale-Up Solution
LF Investment VC Fund
LF Investment is the investment arm of The Lauritzen Foundation, which is the parent company of the shipping companies J. Lauritzen (wholly-owned) and DFDS (42,8% holding). LF Investment has holdings in companies in the oil analysis, measuring equipment, software, biotechnology, and real estate sectors.
Show more
Investment focus
  • Medical, Wellness, Health Care
  • Funding Round
  • Denmark
Portfolio highlights
  • Minervax — We are MinervaX. A clinical stage biotech company focused on making a global impact by developing state-of-the-art vaccines.
Polaris Partners VC Fund · Boston, Massachusetts, United States · 6 investments in the past 12 months
Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • United States, Ireland, Singapore
Portfolio highlights
  • FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
  • Leyden Labs — Leyden Labs helps people live freely by developing products that protect from known and new respiratory viruses.
  • Auron Therapeutics — A differentiated approach to cure cancer.
Seventure Partners VC Fund · Paris, Ile-de-France, France · 5 investments in the past 12 months
Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Series A, Funding Round, Series B
  • France, United States, Germany
Portfolio highlights
  • Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
  • Allozymes — Allozymes applies its proprietary platform technology to rapidly develop novel enzymes, revolutionizing the way that industries manufacture complex natural
  • Vedanta Biosciences — Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing ofrationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily.It was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Bioqube Ventures VC Fund · Hasselt, Limburg, Belgium
Bioqube Ventures is a specialist life sciences venture capital fund investing in European biotech companies developing innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors.Bioqube Venturesinvests through its independent fund “Bioqube Factory Fund I”: … an early stage venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients.… a fit-for-purpose dual investment model – besides more classical investments in first investment rounds, we will have special attention for so called “Create” projects that require additional de-risking prior to creating new ventures. … a hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths.Medtech, healthtech and diagnostics are not part of our current investment scope.
Show more
Investment focus
  • Biotechnology, Therapeutics, Life Science
  • Seed, Series A, Series B
  • United States, France, Denmark
Portfolio highlights
  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • Commit Biologics — Add a description for facebook
  • SynOx Therapeutics — SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors. SynOx Therapeutics raises EUR 37m to develop emactuzumab to improve the lives of patients with tenosynovial giant cell tumors November 16, 2020. It was founded in 2020 and is located in Dublin City, Ireland.
New Enterprise Associates VC Fund · Menlo Park, California, United States · 51 investments in the past 12 months
Foundational partners to ambitious founders at every stage of company-building.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series A, Series B, Series C
  • United States, India, Canada
Portfolio highlights
  • Aurelian — Aurelian is an AI platform designed to automate routes, triage, and resolve non-emergency police calls.
  • Mojo Vision — Mojo Vision is a developer of augmented reality products and platforms intended to invent the future of computing. The company has developed a smart contact lens with a built-in display that gives timely information without interrupting the focus and delivers immediate, powerful, and relevant information without the intrusions of today'smobile devices, enabling users to connect with others at a glance, anytime, anywhere handsfree.Mojo Vision was founded in 2015 and headquartered in Saratoga, California.
  • Strive Health — Strive Health is a built-for-purpose company working with innovative payors and providers to transform kidney care. Strive Health significantly improves patient outcomes and experience with a high-touch, technology-enabled clinical model that cares for chronic kidney disease patients across their entire healthcare journey, from primary care-levelengagement through dialysis. Strive was launched out of Oxeon’s Venture Studio and is backed by New Enterprise Associates, Town Hall Ventures, Echo Health Ventures, and Ascension Ventures.
Sound Bioventures VC Fund · Malmö, Skane Lan, Sweden
Sound Bioventures is a venture capital fund investing in clinical stage companies.
Show more
Investment focus
  • Medical, Biotechnology, Therapeutics
  • Series A, Seed, Series B
  • France, Denmark, United States
Portfolio highlights
  • VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
  • Theolytics — Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing aninternal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
  • AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
CBC Investment Group VC Fund · Gothenburg, Vastra Gotaland, Sweden
CBC Investment Group started in 2009 in the midst of the financial crisis. The banks were on their knees, start-ups of small and medium-sized companies - all of a sudden they saw their credit and credit promises turned into demands for quick repayment and empty words. Serious talented entrepreneurs' ideas and companies risked going completelyunnecessary. In response to this crisis, they started the CBC Investment Group.
Show more
Investment focus
  • Biotechnology, Software, SaaS
  • Funding Round, Seed, Series B
  • Sweden, Denmark, Germany
Portfolio highlights
  • GLX Analytix — GLX Analytix is ​​a biomedical company that develops a new technology to identify a biomarker. The company was founded in 2019 and is based in Copenhagen, Denmark.
  • Swiftly — World's first AI that applies for jobs. Say goodbye to creating CV's, searching and applying for jobs. Let Swiftly do it for you! Welcome to the new age.
  • Hugel Control — HUGEL, Inc. strives to be a global company that continuously creates innovative products, promotes universal health, and improves the quality of life through state-of-the-art technology and creativity.
M Ventures VC Fund · Amsterdam, Noord-Holland, The Netherlands · 14 investments in the past 12 months
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • Anjuna — Anjuna confidential cloud software establishes a secure enclave that isolates and encrypts applications and data in runtime, at rest, and on the network for end-to-end data protection
  • Formo — We're Formo, the future of dairy. Using micro fermentation, we create animal-free cheeses that humans love.
  • NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
BlueYard Capital VC Fund · Berlin, Berlin, Germany · 8 investments in the past 12 months
BlueYard backs founders building the interconnected elements that can become the fabric of our future.
Show more
Investment focus
  • Software, Biotechnology, Cryptocurrency
  • Seed, Series A, Funding Round
  • United States, Germany, United Kingdom
Portfolio highlights
  • Manex — Optimize your production process with our manufacturing optimization agents. Trusted by BMW, Audi, Siemens, Stellantis, BSH, Henkel, and more. Schedule a demo today!
  • Privy — With a few lines of code, securely integrate sensitive data into your product. Build delightful, privacy-preserving experiences without putting your users at risk.
  • Grouphug — Grouphug turns noisy WhatsApp groups into organized, intelligent pages.
Amino Collective VC Fund · Berlin, Berlin, Germany · 3 investments in the past 12 months
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Seed, Pre-Seed, Series A
  • United States, Germany, United Kingdom
Portfolio highlights
  • Hedera Dx — A diagnostics platform that makes liquid biopsies a reality in cancer care
  • Inductive Bio — Bringing the data, ML, software, and expertise needed to rapidly solve your most challenging ADMET problems.
  • Portal Biotech — Portal has created next generation solutions that address the significant opportunities in protein sequencing and metabolomics
Inovo.vc VC Fund · Warsaw, Mazowieckie, Poland · 12 investments in the past 12 months
VC for the most ambitious founders in CEE
Show more
Investment focus
  • Software, Artificial Intelligence, SaaS
  • Seed, Pre-Seed, Series A
  • Poland, United States, United Kingdom
Portfolio highlights
  • Handwave — Handwave is the world’s first biometric wallet and identity platform — replacing wallets, phones, and IDs with a single gesture for in-store payments. Designed for retail, meant for people. End users can easily onboard their palms through the Handwave app by scanning their palm with the phone camera, linking payment and loyalty cards, and thenenjoy frictionless checkout at retail by simply scanning their palm at a payment terminal.
  • Spacelift — Spacelift is the CI/CD for infrastructure-as-code and policy as code. It enables collaboration, automates manual work and compliance, and lets teams customize and automate their workflows.
  • Tracelight — Tracelight is an AI-powered Excel add-in that enhances financial modeling by enabling users to generate formulas from natural language, check for errors, and interact with models using plain English. It helps financial professionals save time, reduce errors, and work more efficiently while maintaining security and data privacy.
Den Midtjyske Inværksätterfond VC Fund · Herning, Midtjylland, Denmark
The Midtjyske Ivaerksätterfond invests in entrepreneurial enterprises that are knowledge-intensive and innovative in order to produce growth, jobs, and value.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Seed
  • Denmark
Portfolio highlights
  • MedicQuant — MedicQuant is a medical equipment manufacturing company developing diagnostic kits for blood anticoagulant properties. The company's novel technology, chip, and instrument, Direct Oral Anticoagulants (DOACs), detect blood levels of the anticoagulants, directly from whole blood.
Bossanova Investimentos VC Fund · São Paulo, Sao Paulo, Brazil · 8 investments in the past 12 months
Somos Bossa Invest
Show more
Investment focus
  • Software, Information Technology, Financial Services
  • Seed, Pre-Seed, Funding Round
  • Brazil, United States, Mexico
Portfolio highlights
  • SenseUp — SenseUp provides IoT, big data, machine learning, and computer vision for the real-time needs of the financial market. It improves the way organizations interact with data by using microintegrations to orchestrate different data sources, consumers, and data flows in support of processes and decision-making.
  • Emitter — Emissor de CTe e NFSe em massa mais simples e rápido, acesse e conheça todas as soluções para sua empresa, emitir CTe de forma simples.
  • Hiperbanco — O Hiperbanco é uma Fintech que oferece diversos serviços financeiros, com destaque para o produto “Banco Digital Whitelabel”. Seu público-alvo abrange empresas de diversos setores, que buscam soluções financeiras flexíveis e personalizadas com sua marca, como Conta, PIX, TED, Boleto, Recargas, Cartão, Emprestimos, dentre outros. Os principaisdiferenciais do Hiperbanco incluem sua abordagem centralizada no cliente, desenhando juntos um produto financeiro único e atuando com tecnologias de ponta.
SEB Venture Capital VC Fund · Stockholm, Stockholms Lan, Sweden
SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.
Show more
Investment focus
  • Software, Information Technology, Financial Services
  • Funding Round, Series A, Series B
  • Sweden, Denmark, United Kingdom
Portfolio highlights
  • EnginZyme — EnginZyme is a biotechnology company that specializes in biocatalysis. It creates products for easy and cost-efficient implementation of biocatalytic processes and helps the chemical industry transition to a sustainable way of operating.The company is driven by a mission to make biocatalysis the first choice for chemical process designersworldwide.
  • Qvantum — Qvantum is driven by a passion for a sustainable future and we are changing the way the cities of Europe are heated.
  • CorPower Ocean — CorPower Ocean is a turnkey supplier of wave energy systems, enabling customers to generate clean electricity from ocean waves - bringing stability to the renewable energy mix.
BankInvest Biomedical Venture VC Fund
BankInvest Biomedical Venture makes investments in research-based biotechnology companies in Europe.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Funding Round, Series B, Series C
  • Denmark, United Kingdom, France
Portfolio highlights
  • F2G — F2G is a biopharmaceutical company developing novel therapies for life-threatening fungal infections.
  • Nereus Pharmaceuticals — Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, infectious diseases, and inflammation. The company uses its marine microbiology technologies for the discovery and development of drug candidates. Its oncology drug candidates include NPI-2358, a tumor vascular disrupting agent forthe treatment of solid tumors; and NPI-0052, a proteasome inhibitor for the treatment of solid tumors, lymphomas, and multiple myeloma. The company was founded in 1998 and is based in San Diego, California.
  • Resistentia Pharmaceuticals — Resistentia Pharmaceuticals, a biopharmaceutical company, develops immunotherapeutic products for allergic asthma and inflammatory disorders. It provides Immunoglobulin E for allergic reactions, including asthma, rhinitis, and dermatitis; and C5a for the treatment of inflammatory conditions, such as rheumatoid arthritis, asthma, and multiplesclerosis. Resistentia Pharmaceuticals AB was founded in 1998 and is based in Uppsala, Sweden.
Dansk Erhvervsinvestering VC Fund
Dansk Erhvervsinvestering is a company that assists individuals with investing.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Funding Round
  • Denmark
Portfolio highlights
  • Genmab — Genmab is an international biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Genmab's discovery, development, and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs. Its primary goal is to improve the lives ofpatients who are in urgent need of new treatment options.
  • PremiTech — Find the best ultrasound system for you including GE ultrasound, Samsung, Mindray, 3D Spine and more. Advanced technology and reliable performance.
VIB VC Fund · Gent, Oost-Vlaanderen, Belgium
Strategic research in on life sciences and biotechnology
Show more
Investment focus
  • Biotechnology, Pharmaceutical, Health Care
  • Series A, Series B, Funding Round
  • Belgium, Brazil, Denmark
Portfolio highlights
  • Protealis — Sustainable plant proteins for Europe​
  • Confo Therapeutics — Confo Therapeutics is a clinical-stage company committed to accelerating novel GPCR-directed medicines for metabolic & endocrine diseases.
  • Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
LS Polaris Innovation Fund VC Fund
The LS Polaris Innovation Fund aims to accelerate the commercial and therapeutic potential of early stage academic research.
Show more
Investment focus
  • Biotechnology, Medical, Biopharma
  • Series A, Series B, Funding Round
  • United States, Denmark
Portfolio highlights
  • Glympse Bio — Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. Glympse Bio’s platformtechnology was originally developed at MIT, and is founded by a team of world-renowned experts in nanomedicine and biomedical engineering.
  • Satellite Bio — Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
  • Muna Therapeutics — Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
Novo Ventures VC Fund · Bagsværd, Hovedstaden, Denmark
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, United Kingdom, Switzerland
Portfolio highlights
  • INBRACE — Swift Health Systems is a stealth stage medical device company developing INBRACE: a revolutionary, easy to use, wide indication, personalized orthodontic system hidden behind the teeth. Our patented self-guiding technology uses light and continuous forces to gently correct your smile with less pain and fewer doctor visits. INBRACE is FDAregistered and a catalyst for disruption in orthodontics. INBRACE increases the number of people who will seek orthodontic treatment by addressing the top concerns for patients while driving practice growth for clinicians. Our platform leverages digital treatment planning, computer modeling, and direct digital manufacturing to create a scalable, patient customized solution that delivers the standard of care across the entire range of orthodontic cases.
  • Theraxyte — Theraxyte is an innovative nano-drug developer. It focuses on the R&D and application of new nano-drugs, especially innovative drugs.
  • Amolyt Pharma — AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Droia Ventures VC Fund · Luxembourg, Luxembourg, Luxembourg · 2 investments in the past 12 months
Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives. We invest in the most promising life science companies.
Show more
Investment focus
  • Biotechnology, Medical, Therapeutics
  • Series A, Series B, Series C
  • United States, Belgium, The Netherlands
Portfolio highlights
  • Judo Bio — Judo Bio is pioneering oligonucleotide medicines delivered to the kidney, opening the way for new treatments for systemic and renal diseases.
  • Vico Therapeutics — Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea
  • Alesta Therapeutics — Alesta Therapeutics is advancing precision small molecule therapies for rare genetic diseases like hypophosphatasia (HPP) and Charcot-Marie-Tooth disease (CMT)
DigitalDx Ventures VC Fund · Menlo Park, California, United States
DigitalDx Ventures is a Silicon Valley Venture firm uniquely positioned to find, support, mentor and grow the outliers in digital healthcare. DDX invests in early stage companies who effectively and efficiently harness the power of artificial intelligence and big data to profoundly impact outcomes in both diagnostics and therapeutics.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Funding Round
  • United States, Canada, Denmark
Portfolio highlights
  • Nephrosant — NephroSant is a fast-paced diagnostic startup founded by physicians, with a team of world-class scientists, engineers and clinicians, focused on applying the founding team's years of clinical research expertise to improve global kidney health.
  • GLX Analytix — GLX Analytix is ​​a biomedical company that develops a new technology to identify a biomarker. The company was founded in 2019 and is based in Copenhagen, Denmark.
  • Optina Diagnostics — Optina Diagnostics is a leader in the early detection of Alzheimer's disease and develops its solutions using Artificial Intelligence.
V-Bio Ventures VC Fund · Gent, Oost-Vlaanderen, Belgium · 2 investments in the past 12 months
V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agriculturalsectors.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Seed
  • Belgium, France, United Kingdom
Portfolio highlights
  • Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer
  • ATB Therapeutics — ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
  • Confo Therapeutics — Confo Therapeutics is a clinical-stage company committed to accelerating novel GPCR-directed medicines for metabolic & endocrine diseases.
Investors by industry
Investors by country
VC (Venture Capital) Funds in Denmark by industry